The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study

Remission is the primary goal of treatment for bipolar disorder I (BDI). Metabolites of noradrenaline and dopamine, 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA), respectively, are reduced by treatment with antipsychotics, but whether these phenomena are caused by antipsychotics...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Masatake, Nishino, Satoshi, Numata, Yukio, Okubo, Yoshiro, Sato, Tadahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074114/
https://www.ncbi.nlm.nih.gov/pubmed/24971450
http://dx.doi.org/10.1371/journal.pone.0100634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074114/
https://www.ncbi.nlm.nih.gov/pubmed/24971450
http://dx.doi.org/10.1371/journal.pone.0100634

Ejemplares similares